MagicJack is not as sophisticated in form or function, but for a trial relationship with Internet calling, especially on the run, it's an inexpensive date.
Here, we determined whether such trial-by-trial relationships vary with age in a cross-sectional design.
To investigate this hypothesis, we examined trial-by-trial relationships between brain activity and response time in twenty healthy adults while they performed a cross-modal selective attention task.
By investigating trial-by-trial relationships between brain activity and response time in humans, we determined that attentional lapses begin with reduced prestimulus activity in anterior cingulate and right prefrontal regions involved in controlling attention.
We investigated neural mechanisms underlying such performance variability using regression-based analyses to examine trial-by-trial relationships between response times (RTs) and different facets of electrical brain activity.
The original searchlight map (with correct class label-trial relationships) was then compared to the permutation threshold map in a voxel-wise manner, only plotting voxels with a discrimination accuracy at or exceeding the permutation threshold.
The degree of correlation between the performance in the discrimination task and subjective visibility was assessed with the non-parametric Kendall τ, which tested the trial-by-trial relationship between the correctness of the discrimination response (a binary variable) and the PA score [24].
Instead, a trial-by-trial relationship between performance and confidence was attenuated in the anterior PFC patient group.
Therefore, we investigated the trial-by-trial relationship between LEP amplitude and response time of 3 types of movements with different defensive values.
To account for spatial correlations and the class label-trial relationship for a given permutation, the permutation scheme was kept constant for each whole-brain searchlight map.
History of 19th- and 20th-century therapeutics and medical evolution, with a focus on the history of antibiotics, the evolving authority of the controlled clinical trial, and relationships among physicians, medical journals, the pharmaceutical industry, and governmental agencies.
